BioMedomics is the clinical diagnostics company that delivers accurate, quick, simple and affordable solutions for use anywhere, anytime. It’s newest product, Sickle SCANTM, is the world’s first multiplexed qualitative point-of-care immunoassay used for the rapid diagnosis of sickle cell disorders. The test is made up of three indicators which detect the presence of hemoglobins A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell samples.